Cannabis composition
AssigneeZelda Therapeutics Operations Pty Ltd.
InventorsHarry Karelis, Mara Gordon, Stewart Smith, Stewart Washer
Life of this patent
Estimating the term…
Abstract
The invention relates to a method for treating cancer or a symptom associated with cancer. In particular, the present invention relates to a method for treating cancer or a symptom associated with cancer, comprising administering to a patient in need thereof an effective amount of the pharmaceutical composition comprising a Cannabis extract that comprises Δ9-tetrahydrocannabinol (THC) in an amount of from 50% to 99% by weight of the pharmaceutical composition.
Claims9
A pharmaceutical composition comprising a Cannabis extract and optionally one or more pharmaceutically acceptable carriers, diluents, adjuvants, excipients or any combination thereof, the Cannabis extract comprising a cannabinoid fraction and a terpene fraction, wherein the Cannabis extract comprises:
- A:
- ≥0.3% w/w of the terpene fraction;
- ≥50% w/w Δ9-Tetrahydrocannabinol (THC);
- ≥0.3% w/w Cannabigerol (CBG);
- and
- ≤0.5% w/w Cannabinol (CBN);
- wherein the terpene fraction comprises:
- ß-caryophyllene in an amount of at least 11% by weight of the terpene fraction,
- linalool in an amount of at least 5% by weight of the terpene fraction;
- and
- ß-pinene in an amount of at least 1% by weight of the terpene fraction.
Dependencies are inferred from the claim text.